Alivira Spain celebrates the first edition of its InfoDay
On June 11, Alivira Spain held the first edition of its InfoDay, an internal event designed to share strategic information, foster collaboration among teams, and reinforce the company’s vision for the future. During the event, the evolution of the business and the key strategic priorities that will shape Alivira’s development in the coming years were […]
Alivira Announces Collaboration with the UAB Veterinary Hospital
Alivira has announced the start of its collaboration with the Veterinary Hospital of the Autonomous University of Barcelona (HV-UAB), with the aim of promoting joint projects in the field of animal health. This partnership reinforces Alivira’s commitment to advancing evidence-based veterinary medicine by supporting improvements in clinical protocols, continuous professional development, industry training, and the […]
Alivira further strengthens its European presence in the companion animal sector through the acquisition of Italy-based BioForLife.
The acquisition marks a strategic entry into one of Europe’s largest companion animal health markets and accelerates the company’s global growth ambitions in pet care. Viyash Scientific Limited (Viyash), through its subsidiary Alivira Animal Health Limited (Alivira), has signed a binding agreement to acquire 100% of BioForLife Italia S.r.l. (BFL), a leading companion animal healthcare […]
Alivira celebrates its annual Global Convention in Málaga
From April 20 to 24, Alivira held the 4th edition of its Global Formulations Convention, one of the company’s most important strategic events of the year. On this occasion, the event took place in Málaga, bringing together 55 participants from different countries and affiliates across the group. During the event, three days were dedicated to […]
During the XXVIII Pig Farming Conference of the UAB and the AVPC
Our Alivira Sales and Marketing team for Production Animals and Phytosolutions took part on January 29 and 30 in the XXVIII Pig Farming Conference organized by the UAB and the AVPC. This key event provides an opportunity to share knowledge and ideas with colleagues from the swine sector and to catch up on the most […]
Merry Christmas and Happy New Year
During this special season, we want to express our gratitude to all who share with us the commitment to animal health and well-being. Christmas is a time to reflect on what we have achieved together and to recognize the efforts of veterinarians, distributors, producers, and collaborators who work every day toward a healthier and more […]
Alivira Launches Diclacare® in Several European Markets
Diclacare® 2.5 mg/ml is the new oral suspension for lambs and calves based on diclazuril from the Alivira group. Diclacare® 2.5 mg/ml is authorized for the prevention of clinical signs of coccidiosis caused by Eimeria crandallis and Eimeria ovinoidalis in lambs, and Eimeria bovis and Eimeria zuernii in calves. When administered before the onset of […]
Alivira opens a new R&D Center in Turkey
This October, Alivira inaugurated a new global R&D center in Ankara, Turkey. With the opening of this new research facility, Alivira Turkey strengthens its team and expands its resources, equipment, and capacity—key factors for executing new strategic projects for the group and accelerating their implementation. With this new center, we are taking our vision of […]
Access VetMed brings together 70 leaders from the European veterinary generics industry at a meeting hosted by Alivira
Access VetMed held its 23rd Annual CEOs Meeting on the 18th and 19th of September in Barcelona. The event, organized by Alivira at the Dolce Barcelona Resort, brought together 70 CEOs and senior executives from companies that are part of the association. The European veterinary generics industry is currently preparing a package of urgent measures […]
Alivira at the 27th ANEMBE International Congress
As a regular collaborating company, Alivira once again took part in the ANEMBE International Congress, whose latest edition was held from May 28 to 30 in Vitoria. With the launch of Diclacare and injectable Taurador, we have expanded our portfolio of antiparasitic products for ruminants. These two additions are part of a broader pipeline of […]
